Inhibition of Bruton's tyrosine kinase regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation
Background and Purpose Currently there are limited medicines available for the treatment of metabolic inflammation in diseases such as obesity and type 2 diabetes (T2D). Although initially associated with B‐ells, Bruton's tyrosine kinase (BTK) is present in a wide variety of cells including mon...
Главные авторы: | Purvis, GSD, Collino, M, Aranda-Tavio, H, Chiazza, F, O'Riordan, CE, Zeboudj, L, Mohammad, S, Collotta, D, Verta, R, Guisot, NES, Bunyard, P, Yaqoob, MM, Greaves, DR, Thiemermann, C |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Wiley
2020
|
Схожие документы
-
Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
по: O'Riordan, CE, и др.
Опубликовано: (2019) -
Bruton's TK regulates myeloid cell recruitment during acute inflammation
по: Purvis, GSD, и др.
Опубликовано: (2022) -
X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure
по: O'Riordan, CE, и др.
Опубликовано: (2020) -
Brutinib has anti‐inflammatory and anti‐diabetic effects in a model of HFD‐ induced insulin resistance and diabetic nephropathy
по: Purvis, GS, и др.
Опубликовано: (2019) -
Quantitative proteomics to unravel NLRP3 inflammasome biology
по: Liang, Z
Опубликовано: (2022)